Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia?
De Haas V, Kaspers GJ, Oosten L, Bresters D, Pieters R, Van Der Velden VH, Van Wering ER, Van Den Berg H, Van Der Schoot CE. De Haas V, et al. Br J Haematol. 2002 Sep;118(4):1190-1. doi: 10.1046/j.1365-2141.2002.36211.x. Br J Haematol. 2002. PMID: 12199807 Free article. No abstract available.
High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome.
Balgobind BV, Zwaan CM, Reinhardt D, Arentsen-Peters TJ, Hollink IH, de Haas V, Kaspers GJ, de Bont ES, Baruchel A, Stary J, Meyer C, Marschalek R, Creutzig U, den Boer ML, Pieters R, van den Heuvel-Eibrink MM. Balgobind BV, et al. Among authors: de haas v, de bont es. Leukemia. 2010 Dec;24(12):2048-55. doi: 10.1038/leu.2010.211. Epub 2010 Sep 23. Leukemia. 2010. PMID: 20861917
High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23).
Kuipers JE, Coenen EA, Balgobind BV, Stary J, Baruchel A, de Haas V, de Bont ES, Reinhardt D, Kaspers GJ, Cloos J, Danen-van Oorschot AA, den Boer ML, Marschalek R, Meyer C, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM. Kuipers JE, et al. Among authors: de haas v, de bont es. Blood. 2011 Jan 20;117(3):928-35. doi: 10.1182/blood-2010-05-286138. Epub 2010 Nov 2. Blood. 2011. PMID: 21045196 Free article.
Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia.
Waanders E, van der Velden VH, van der Schoot CE, van Leeuwen FN, van Reijmersdal SV, de Haas V, Veerman AJ, van Kessel AG, Hoogerbrugge PM, Kuiper RP, van Dongen JJ. Waanders E, et al. Among authors: de haas v. Leukemia. 2011 Feb;25(2):254-8. doi: 10.1038/leu.2010.275. Epub 2010 Nov 19. Leukemia. 2011. PMID: 21102428
Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia.
Homminga I, Pieters R, Langerak AW, de Rooi JJ, Stubbs A, Verstegen M, Vuerhard M, Buijs-Gladdines J, Kooi C, Klous P, van Vlierberghe P, Ferrando AA, Cayuela JM, Verhaaf B, Beverloo HB, Horstmann M, de Haas V, Wiekmeijer AS, Pike-Overzet K, Staal FJ, de Laat W, Soulier J, Sigaux F, Meijerink JP. Homminga I, et al. Among authors: de haas v, de laat w, de rooi jj. Cancer Cell. 2011 Apr 12;19(4):484-97. doi: 10.1016/j.ccr.2011.02.008. Cancer Cell. 2011. PMID: 21481790 Free article.
Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia.
Blink M, Buitenkamp TD, van den Heuvel-Eibrink MM, Danen-van Oorschot AA, de Haas V, Reinhardt D, Klusmann JH, Zimmermann M, Devidas M, Carroll AJ, Basso G, Pession A, Hasle H, Pieters R, Rabin KR, Izraeli S, Zwaan CM. Blink M, et al. Among authors: de haas v. Leukemia. 2011 Aug;25(8):1365-8. doi: 10.1038/leu.2011.86. Epub 2011 May 3. Leukemia. 2011. PMID: 21537335 No abstract available.
135 results